Campbell & Co Investment Adviser’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $200K | Buy |
+19,668
| New | +$200K | 0.01% | 1057 |
|
2024
Q4 | – | Sell |
-27,241
| Closed | -$279K | – | 1279 |
|
2024
Q3 | $279K | Buy |
+27,241
| New | +$279K | 0.02% | 928 |
|
2024
Q2 | – | Sell |
-96,468
| Closed | -$1.33M | – | 1273 |
|
2024
Q1 | $1.33M | Buy |
96,468
+58,849
| +156% | +$809K | 0.11% | 279 |
|
2023
Q4 | $346K | Buy |
+37,619
| New | +$346K | 0.03% | 863 |
|